Category: us corporate news

us corporate news

Tvardi Therapeutics, Inc. Announces Capital on Demand™ Sales Agreement and NASDAQ Listing Under Symbol TVRD

Minichart

July 18, 2026

Tvardi Therapeutics, Inc. Files Form 8-K: Update on Capital ...

Continue Reading 0

us corporate news

Lindsay Corporation Announces Transition Services Agreement and Executive Leadership Changes in 2026

Minichart

July 18, 2026

Lindsay Corporation Announces CFO Transition and New Compens...

Continue Reading 0

us corporate news

International Paper Company Announces New Directors and Board Changes – July 2026 Form 8-K Filing

Minichart

July 18, 2026

International Paper Company Announces Significant Changes to...

Continue Reading 0

us corporate news

Vaxart, Inc. Files 8-K SEC Report Detailing Company Information and Board Vote Results – July 16, 2026

Minichart

July 18, 2026

Vaxart Announces Results of 2026 Annual Meeting of Stockhold...

Continue Reading 0

us corporate news

Spire Global Appoints Eric Mellinger as Chief Commercial Officer to Accelerate Global Revenue Growth

Minichart

July 18, 2026

Spire Global Appoints Eric Mellinger as Chief Commercial Off...

Continue Reading 0

us corporate news

2026 Financial Performance Highlights and Key Metrics – Company Stock, Income, and Efficiency Ratios

Minichart

July 18, 2026

Ames National Corporation Reports Robust Q2 2026 Earnings an...

Continue Reading 0

us corporate news

CRH plc 8-K Filing: NYSE-Listed Ordinary Shares and Guaranteed Notes Key Details (July 2026)

Minichart

July 18, 2026

CRH plc Files Form 8-K: Key Developments and Implications fo...

Continue Reading 0

us corporate news

Hims & Hers Health, Inc. Files 8-K with SEC: Key Details on Company Info, Stock, and Compliance (July 2026) 1

Minichart

July 18, 2026

Hims & Hers Health, Inc. Announces Resignation of Chief Acco...

Continue Reading 0

us corporate news

Adobe Inc. 8-K Filing July 2026: Entity Information, Common Stock Details, and SEC Compliance

Minichart

July 18, 2026

Adobe Inc. Files 8-K Report: Executive Compensation Committe...

Continue Reading 0

us corporate news

Cadrenal Therapeutics Announces Separation Agreement with James J. Ferguson III – SEC Form 8-K Filing July 2026

Minichart

July 18, 2026

Cadrenal Therapeutics, Inc. - Significant Corporate Update: ...

Continue Reading 0